These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 6815291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M, Fritschi J, Lämmle B, Tran TH, Marbet GA, Berger W, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):138-43. PubMed ID: 6084321
    [Abstract] [Full Text] [Related]

  • 3. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J, Dhennin C, Guilbaud J.
    Nouv Rev Fr Hematol (1978); 1982 Oct 31; 24(6):375-81. PubMed ID: 6188103
    [Abstract] [Full Text] [Related]

  • 4. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK, Schmaier AH, Colman RW.
    Pathobiol Annu; 1982 Oct 31; 12():35-64. PubMed ID: 6186978
    [No Abstract] [Full Text] [Related]

  • 5. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
    Koert M, Nowak-Göttl U, Kreuz W, Grüttner HP, Kornhuber B, Breddin HK.
    Klin Padiatr; 1991 Oct 31; 203(6):429-32. PubMed ID: 1721940
    [Abstract] [Full Text] [Related]

  • 6. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN, Volokhonskaia LI, Kizim AI, Pogorelaia NF.
    Ukr Biokhim Zh (1978); 1983 Oct 31; 55(3):295-301. PubMed ID: 6553425
    [Abstract] [Full Text] [Related]

  • 7. Hematological prospect in 1981, particularly in the field of coagulation and fibrinolysis.
    Abe T.
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb 31; 45(1):11-16. PubMed ID: 6810621
    [No Abstract] [Full Text] [Related]

  • 8. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr 31; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 9. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR, Langley PG, Hughes RD, Izumi S, Williams R.
    Hepatology; 1993 Dec 31; 18(6):1350-6. PubMed ID: 8244260
    [Abstract] [Full Text] [Related]

  • 10. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK, McRoyan CJ, Sauter KL, Liu PI, Daniel SJ.
    Ann Clin Lab Sci; 1985 Dec 31; 15(2):165-70. PubMed ID: 3158265
    [Abstract] [Full Text] [Related]

  • 11. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
    Di Cesare E, Quartarone M, Cucinotta D, Coppolino E, Squadrito G.
    Minerva Med; 1979 May 07; 70(22):1597-9. PubMed ID: 450299
    [No Abstract] [Full Text] [Related]

  • 12. [Kallikreinogen-kallikrein system in the blood of patients with vascular complications of diabetes].
    Kaniak J, Kotschy M, Kurzawska M, Ciosek W.
    Pol Tyg Lek; 1977 May 09; 32(19):705-7. PubMed ID: 866255
    [No Abstract] [Full Text] [Related]

  • 13. [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].
    Kotschy M, Drewniak W, Graczykowska-Koczorowska A, Listopadzki D.
    Pol Tyg Lek; 1977 May 09; 47(1-2):17-8. PubMed ID: 1409034
    [Abstract] [Full Text] [Related]

  • 14. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
    Chmielewski J.
    Wiad Lek; 1973 Apr 01; 26(7):615-7. PubMed ID: 4573502
    [No Abstract] [Full Text] [Related]

  • 15. [Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy].
    Sánchez Martín S, García Díez LC, García Marcos MA, Miralles García JM.
    Rev Clin Esp; 1983 May 15; 169(3):189-90. PubMed ID: 6612032
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in fibrinolysis in diabetes mellitus].
    Tóthová E, Mechír J, Suchmanová I, Mudronová B.
    Vnitr Lek; 1990 Feb 15; 36(2):163-9. PubMed ID: 2336814
    [Abstract] [Full Text] [Related]

  • 17. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 15; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 18. Diabetic retinopathy and the fibrinolytic system.
    Almér LO, Pandolfi M, Nilsson IM.
    Diabetes; 1975 Jun 15; 24(6):529-34. PubMed ID: 49282
    [Abstract] [Full Text] [Related]

  • 19. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Cordova C, Musca A, Violi F, Alessandri C, Ferro D, Piromalli A, Balsano F.
    Haemostasis; 1984 Jun 15; 14(2):218-22. PubMed ID: 6564063
    [Abstract] [Full Text] [Related]

  • 20. The influence of L-asparaginase therapy on the fibrinolytic system.
    Vellenga E, Kluft C, Mulder NH, Wijngaards G, Nieweg HO.
    Br J Haematol; 1984 Jun 15; 57(2):247-54. PubMed ID: 6203549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.